Smoking cessation, weight gain, and DRD4 -521 genotype
We investigated change in body mass index following long-term smoking cessation in a representative cohort of treatment-seeking heavy smokers in the United Kingdom, to determine the extent of long-term weight gain in successful quitters versus continuing smokers. We further investigated whether DRD4...
Asıl Yazarlar: | Munafò, MR, Murphy, M, Johnstone, E |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2006
|
Benzer Materyaller
-
Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial.
Yazar:: Munafò, MR, ve diğerleri
Baskı/Yayın Bilgisi: (2009) -
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch.
Yazar:: David, S, ve diğerleri
Baskı/Yayın Bilgisi: (2008) -
Smoking status moderates the association of the dopamine D4 receptor (DRD4) gene VNTR polymorphism with selective processing of smoking-related cues.
Yazar:: Munafò, MR, ve diğerleri
Baskı/Yayın Bilgisi: (2008) -
A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation.
Yazar:: Welton, N, ve diğerleri
Baskı/Yayın Bilgisi: (2008) -
Lack of association of DRD2 rs1800497 (Taq1A) polymorphism with smoking cessation in a nicotine replacement therapy randomized trial
Yazar:: Munafo, M, ve diğerleri
Baskı/Yayın Bilgisi: (2009)